New Strategies in Cancer Therapeutics
At the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, novel strategies were presented.
These strategies move beyond traditional antibody-drug conjugate (ADC) payloads and targets.
Several presentations highlighted novel strategies during the first poster session.
AACR-NCI-EORTC 2025 reshapes the field with new approaches.
Author's summary: New cancer strategies emerge at AACR-NCI-EORTC 2025.